Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Repurposing an antipsychotic drug to treat various types of cancer

To treat some of the psychosis issues associated with Parkinson's disease, physicians often prescribe pimavanserin, an antipsychotic drug that acts within the brain to prevent hallucinations and delusions.

28 Jul 2022

Physical and mental activities may help reduce dementia risk

Physical and mental activities, such as household chores, exercise, and visiting with family and friends, may help lower the risk of dementia, according to a new study published in the July 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Jul 2022

People who eat more ultra-processed foods may have higher risk of dementia

People who eat the highest amounts of ultra-processed foods like soft drinks, chips and cookies may have a higher risk of developing dementia than those who eat the lowest amounts, according to a new study published in the July 27, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

27 Jul 2022

Epigenetic age acceleration could be used as a biomarker to estimate functional and cognitive aging

A first-of-its-kind study of 1,813 older women suggests that the accelerated biological aging of the body - epigenetic age acceleration specifically - is associated with lower odds of living to be 90 years old and also being physically mobile and having intact mental function.

27 Jul 2022

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

A sensor identifies misfolded protein biomarkers in the blood. This offers a chance to detect Alzheimer's disease before any symptoms occur. Researchers intend to bring it to market maturity.

21 Jul 2022

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

The Focused Ultrasound Foundation and the Children's Tumor Foundation (CTF) have established a partnership to advance innovative, noninvasive treatments in pediatrics.

21 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

Benefits of physical, mental activity on thinking may vary for men and women, study suggests

Studies have shown that physical and mental activity help preserve thinking skills and delay dementia. A new study suggests that these benefits may vary for men and women.

20 Jul 2022

Simple, effective method can detect protein misfolding at an early stage of neurodegenerative disease

Neurodegenerative diseases like Alzheimer's disease or Parkinson's disease are caused by folding errors (misfolding) in proteins or peptides, i.e. by changes in their spatial structure.

20 Jul 2022

New method could facilitate the diagnosis of early-stage Parkinson's disease

Parkinson's is a progressive and debilitating disease of the brain that eventually compromises patients' ability to walk and even to talk. Its diagnosis is complex, and in the early stages – impossible.

15 Jul 2022

Using mobile and wearable proprietary technologies to remotely monitor Parkinson’s disease symptoms

Parkinson's Disease affects 10 million people worldwide and its symptoms include tremors in the fingers and hands, small handwriting, loss of smell, walking difficulties, dizziness, and others.

15 Jul 2022

Exploring the connection between Parkinson's disease and gut microbiota to uncover potential therapeutic targets

Scientists have published a new review focusing on the relationship between PD and gut microbiota.

15 Jul 2022

The successful transplantation of genetically engineered pig hearts into recently deceased humans

Researchers successfully transplanted two genetically engineered heart pigs into recently deceased humans in June and July 2022.

14 Jul 2022

Few people may have symptoms of depression years before their stroke, finds study

While depression is a common problem for people who have had a stroke, some people may have symptoms of depression years before their stroke, according to a study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Jul 2022

People with non-alcoholic fatty liver disease may have higher risk of dementia

People who have non-alcoholic fatty liver disease, a buildup of fat cells in the liver, may have a higher risk of dementia, according to a new study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Jul 2022

New chemical biological tools could help better understand the progression of Parkinson's disease

Researchers are a step closer to understanding how Parkinson's disease develops and progresses thanks to chemical biological tools developed at Simon Fraser University.

13 Jul 2022

Study reveals a new molecular perspective to the cause of Gaucher's disease

A study by researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute at Texas Children's Hospital and collaborating institutions is the first to associate neuronal activity to the levels of sphingolipids, a type of fat, in brain cells.

13 Jul 2022

Psilocybin microdosing associated with mood and mental health improvements

The latest study to examine how tiny amounts of psychedelics can impact mental health provides further evidence of the therapeutic potential of microdosing.

11 Jul 2022

Research suggests a new pathway for developing Parkinson's disease

There is currently no cure for Parkinson's disease (PD), and one of the main difficulties for developing treatments is that we don't know exactly how or why the disease occurs.

4 Jul 2022

Key protein α-synuclein linked to inflammation and Parkinson's disease

Currently, there are no disease modifying therapies for Parkinson's disease that can change the progression of the disease. An international team of scientists led by faculty at the University of Colorado Anschutz Medical Campus is hoping to change that.

30 Jun 2022

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Repurposing an antipsychotic drug to treat various types of cancer

Physical and mental activities may help reduce dementia risk

People who eat more ultra-processed foods may have higher risk of dementia

Epigenetic age acceleration could be used as a biomarker to estimate functional and cognitive aging

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

New study to investigate focused ultrasound's role in addressing neurofibromatosis type 2

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Benefits of physical, mental activity on thinking may vary for men and women, study suggests

Simple, effective method can detect protein misfolding at an early stage of neurodegenerative disease

New method could facilitate the diagnosis of early-stage Parkinson's disease

Using mobile and wearable proprietary technologies to remotely monitor Parkinson’s disease symptoms

Exploring the connection between Parkinson's disease and gut microbiota to uncover potential therapeutic targets

The successful transplantation of genetically engineered pig hearts into recently deceased humans

Few people may have symptoms of depression years before their stroke, finds study

People with non-alcoholic fatty liver disease may have higher risk of dementia

New chemical biological tools could help better understand the progression of Parkinson's disease

Study reveals a new molecular perspective to the cause of Gaucher's disease

Psilocybin microdosing associated with mood and mental health improvements

Research suggests a new pathway for developing Parkinson's disease

Key protein α-synuclein linked to inflammation and Parkinson's disease

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in